Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Insys cannabinoid drug Syndros given Schedule II status
Insys cannabinoid drug Syndros given Schedule II status
Insys cannabinoid drug Syndros given Schedule II status
Submitted by
admin
on March 25, 2017 - 12:25pm
Source:
BioPharma Dive
News Tags:
Insys
cannabis
Syndros
HIV-related anorexia
chemotherapy-induced nausea and vomiting
Headline:
Insys cannabinoid drug Syndros given Schedule II status
Do Not Allow Advertisers to Use My Personal information
